Csenge Advisory Group Bristol Myers Squibb CO Transaction History

Csenge Advisory Group

$1.81 Billion
Q4 2024

A detailed history of Csenge Advisory Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Csenge Advisory Group holds 9,879 shares of BMY stock, worth $507,187. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,879

Previous 9,969 0.9%

Holding current value

$507,187

Previous $515,000 8.35%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$51.92 - $59.94 $4,672 - $5,394	-90 Reduced 0.9%	9,879 $558,000
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $395,370 - $515,895	9,969 New	9,969 $515,000
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $48,843 - $55,379	1,018 Added 12.02%	9,484 $514,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $129,732 - $154,806	-2,676 Reduced 24.02%	8,466 $434,000
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $14,530 - $16,247	-251 Reduced 2.2%	11,142 $646,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $50,585 - $56,167	794 Added 7.49%	11,393 $728,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $196,341 - $222,695	2,988 Added 39.26%	10,599 $734,000
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $13,490 - $15,974	197 Added 2.66%	7,611 $547,000
Q3 2022 Oct 04, 2022	SELL	$0.13 - $76.84 $284 - $168,433	-2,192 Reduced 22.82%	7,414 $527,000
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $85,110 - $93,736	1,172 Added 13.9%	9,606 $740,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $98,613 - $118,246	-1,604 Reduced 15.98%	8,434 $616,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $260,159 - $303,284	4,851 Added 93.52%	10,038 $668,000
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $287,033 - $336,222	-4,851 Reduced 48.33%	5,187 $309,000
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $128,958 - $140,435	-2,083 Reduced 17.19%	10,038 $668,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $36,138 - $40,644	-609 Reduced 4.78%	12,121 $759,000
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $59,414 - $67,327	-1,029 Reduced 7.48%	12,730 $790,000
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $122,842 - $136,125	-2,139 Reduced 13.45%	13,759 $794,000
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $31,685 - $37,044	-578 Reduced 3.51%	15,898 $935,000
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $19,441 - $28,253	-419 Reduced 2.48%	16,476 $918,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $276,855 - $361,132	5,626 Added 49.92%	16,895 $1.08 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $206,964 - $245,385	-4,839 Reduced 30.04%	11,269 $572,000
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $49,394 - $54,619	-1,107 Reduced 6.43%	16,108 $742,000
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $288,813 - $344,373	6,401 Added 59.19%	17,215 $821,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $87,231 - $113,118	1,789 Added 19.82%	10,814 $562,000
Q3 2018 Nov 19, 2018	BUY	$55.19 - $62.25 $498,089 - $561,806	9,025 New	9,025 $474,000

Others Institutions Holding BMY

# of Institutions

2,775

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $109B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account

Csenge Advisory Group Bristol Myers Squibb CO Transaction History